Market Highlights

• Genentech has announced plans to invest $700.0 million in Holly Springs to build a manufacturing facility, expected to generate over 400 new jobs.
• Atsena Therapeutics, a gene therapy developer for inherited retinal diseases, raised $150.0 million to support its clinical program and advance preclinical therapies.
• Venture capital (VC) activity remains strong in Raleigh-Durham, with $674.3 million raised across 51 deals, accounting for an impressive 76.8 percent of the region’s total funding in 2024.

Read the full report